Cost analysis of the stroke volume variation guided perioperative hemodynamic optimization - an economic evaluation of the SVVOPT trial results
Language English Country England, Great Britain Media electronic-ecollection
Document type Journal Article
PubMed
24891837
PubMed Central
PMC4041635
DOI
10.1186/1471-2253-14-40
PII: 1471-2253-14-40
Knihovny.cz E-resources
- Keywords
- Cost-effectiveness, Fluid optimization, Hemodynamic optimization,
- MeSH
- Cost-Benefit Analysis MeSH
- Hemodynamics * MeSH
- Humans MeSH
- Costs and Cost Analysis MeSH
- Perioperative Care economics methods MeSH
- Monitoring, Intraoperative economics methods MeSH
- Intraoperative Care economics methods MeSH
- Retrospective Studies MeSH
- Fluid Therapy economics methods MeSH
- Stroke Volume * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Perioperative goal directed therapy (GDT) can substantially improve the outcomes of high risk surgical patients as shown by many clinical studies. However, the approach needs initial investment and can increase the already very high staff workload. These economic imperatives may be at least partly responsible for weak adherence to the GDT concept. A few models are available for the evaluation of GDT cost-effectiveness, but studies of real economic data based on a recent clinical trial are lacking. In order to address this we have performed a retrospective analysis of the data from the "Intraoperative fluid optimization using stroke volume variation in high risk surgical patients" trial (ISRCTN95085011). METHODS: The health-care payers perspective was used in order to evaluate the perioperative hemodynamic optimization costs. Hospital invoices from all patients included in the trial were extracted. A direct comparison between the study (GDT, N = 60) and control (N = 60) groups was performed. A cost tree was constructed and major cost drivers evaluated. RESULTS: The trial showed a significant improvement in clinical outcomes for GDT treated patients. The mean cost per patient were lower in the GDT group 2877 ± 2336€ vs. 3371 ± 3238€ in controls, but without reaching a statistical significance (p = 0.596). The mean cost of all items except for intraoperative monitoring and infusions were lower for GDT than control but due to the high variability they all failed to reach statistical significance. Those costs associated with clinical care (68 ± 177€ vs. 212 ± 593€; p = 0.023) and ward stay costs (213 ± 108€ vs. 349 ± 467€; p = 0.082) were the most important differences in favour of the GDT group. CONCLUSIONS: Intraoperative fluid optimization with the use of stroke volume variation and Vigileo/FloTrac system showed not only a substantial improvement of morbidity, but was associated with an economic benefit. The cost-savings observed in the overall costs of postoperative care trend to offset the investment needed to run the GDT strategy and intraoperative monitoring. TRIAL REGISTRATION: ISRCTN95085011.
See more in PubMed
Dalfino L, Giglio MT, Puntillo F, Marucci M, Brienza N. Haemodynamic goal-directed therapy and postoperative infections: earlier is better. a systematic review and meta-analysis. Crit Care. 2011;15(3):R154. doi: 10.1186/cc10284. PubMed DOI PMC
Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia P, Pietropaoli P. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007;132(6):1817–1824. doi: 10.1378/chest.07-0621. PubMed DOI
Brienza N, Giglio MT, Marucci M, Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med. 2009;37(6):2079–2090. doi: 10.1097/CCM.0b013e3181a00a43. PubMed DOI
Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesthesia & Analgesia. 2011;112(6):1392–1402. doi: 10.1213/ANE.0b013e3181eeaae5. PubMed DOI
Cannesson M, Pestel G, Ricks C, Hoeft A, Perel A. Hemodynamic monitoring and management in patients undergoing high risk surgery: a survey among North American and European anesthesiologists. Crit Care. 2011;15(4):R197. doi: 10.1186/cc10364. PubMed DOI PMC
Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA. 1993;270(22):2699–2707. doi: 10.1001/jama.1993.03510220055034. PubMed DOI
Guest JF, Boyd O, Hart WM, Grounds RM, Bennett ED. A cost analysis of a treatment policy of a deliberate perioperative increase in oxygen delivery in high risk surgical patients. Intensive Care Med. 1997;23(1):85–90. doi: 10.1007/s001340050295. PubMed DOI
Fenwick E, Wilson J, Sculpher M, Claxton K. Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysis. Intensive Care Med. 2002;28(5):599–608. doi: 10.1007/s00134-002-1257-y. PubMed DOI
Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ. 1999;318(7191):1099–1103. doi: 10.1136/bmj.318.7191.1099. PubMed DOI PMC
Mowatt G, Houston G, Hernndez R, De Verteuil R, Fraser C, Cuthbertson B, Vale L. Systematic review of the clinical effectiveness and cost-effectiveness of oesophageal Doppler monitoring in critically ill and high-risk surgical patients. Health Technol Assess (Rockv) 2009;13(7):1–1. PubMed
Bartha E, Davidson T, Hommel A, Thorngren KG, Carlsson P, Kalman S. Cost-effectiveness analysis of goal-directed hemodynamic treatment of elderly hip fracture patients: before clinical research starts. Anesthesiology. 2012;117(3):519–530. doi: 10.1097/ALN.0b013e3182655eb2. PubMed DOI
Benes J, Chytra I, Altmann P, Hluchy M, Kasal E, Svitak R, Pradl R, Stepan M. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care. 2010;14(3):R118. doi: 10.1186/cc9070. PubMed DOI PMC
Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998;3(4):233–245. PubMed
Braga M, Gianotti L, Vignali A, Schmid A, Nespoli L, Di Carlo V. Hospital resources consumed for surgical morbidity: effects of preoperative arginine and omega-3 fatty acid supplementation on costs. Nutrition. 2005;21(11–12):1078–1086. PubMed
Defez C, Fabbro-Peray P, Cazaban M, Boudemaghe T, Sotto A, Daurès J. Additional direct medical costs of nosocomial infections: an estimation from a cohort of patients in a French university hospital. J Hosp Infect. 2008;68(2):130–136. doi: 10.1016/j.jhin.2007.11.005. PubMed DOI
Michard F. The burden of high-risk surgery and the potential benefit of goal-directed strategies. Crit Care. 2011;15(5):447. doi: 10.1186/cc10473. PubMed DOI PMC